rs11269962 — IRF5 Regulatory

A 14-bp indel 2.2 kb upstream of IRF5 that is the most strongly associated cis-regulatory variant for IRF5 expression; the deletion allele tags protective haplotypes with lower SLE susceptibility, representing the third independent cis-regulatory signal in the IRF5 5' haplotype block alongside rs13245639 and rs729302

See your personal result for IRF5

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

IRF5 rs11269962 — The Upstream Rheostat: IRF5's Strongest Expression Signal

Interferon Regulatory Factor 5 (IRF5) is the molecular conductor of the type I interferon symphony — a transcription factor that, when overactive, drives the chronic immune hyperactivation underlying systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis, and Sjögren syndrome. Among the many variants scattered across the IRF5 locus, rs11269962 holds a distinctive position: of all the polymorphisms tested, it shows the strongest statistical association with IRF5 mRNA expression levels by RNA-seq11 strongest statistical association with IRF5 mRNA expression levels by RNA-seq
P=0.002, Fernández-Hernández et al. 2013 — identified from a screen of 26 cis-regulatory candidates across the IRF5 5' region. It sits 2.2 kilobases upstream of the IRF5 transcription start site, within the same 5' regulatory haplotype block as rs729302 and rs13245639, and serves as the third independent functional tag for the protective haplotype architecture at this locus.

The Mechanism

rs11269962 is a 14-base-pair insertion/deletion polymorphism embedded in the IRF5 5' upstream regulatory region. The two alleles — insertion (I, the major allele) and deletion (D, the minor allele) — create structurally different chromatin environments that interact differentially with nuclear transcription factors.

In electrophoretic mobility shift assays (EMSA)22 electrophoretic mobility shift assays (EMSA)
A technique that detects protein–DNA binding by observing whether a DNA fragment "shifts" to a slower mobility when complexed with nuclear proteins using WIL2-NS B lymphoblastoid nuclear extracts, the insertion (I) allele showed a specific delayed band absent with the deletion allele — meaning the insertion sequence recruits a transcription factor that the deletion sequence does not. Paradoxically, luciferase reporter assays showed that the construct carrying the insertion allele produced lower transcriptional output than the deletion-allele construct, indicating that the bound factor is repressive rather than activating. The deletion allele, by removing this binding site, releases this repression and increases basal IRF5 transcription in isolation.

At the haplotype level, however, the net effect reverses. The deletion (D) allele sits predominantly on haplotypes H2 and H3 — the low-expression protective haplotypes that correlate with reduced IRF5 mRNA and lower SLE susceptibility — while the insertion (I) allele is enriched on neutral-to-risk haplotypes. This haplotype-level effect reflects the combined regulatory architecture of all variants in the block rather than the isolated effect of rs11269962 alone. The rs11269962 signal is most meaningfully interpreted in its haplotype context: deletion allele → protective haplotype33 deletion allele → protective haplotype
The D allele has r²=0.36 with rs729302-C (protective) in European samples but is below r²=0.05 in Asian and African populations — it partially tags the protective block but also captures independent regulatory variation.

The Evidence

Fernández-Hernández et al. (2013) performed a systematic functional screen of 26 cis-regulatory candidate polymorphisms across the IRF5 5' region. Only four passed dual criteria of allele-specific EMSA binding and reporter gene expression differences: rs11269962, rs13245639, the CGGGG promoter indel, and rs12706860. Among these, rs11269962 stood out as the variant most significantly associated with IRF5 mRNA levels measured directly by RNA-seq — the gold standard for quantifying transcript abundance. This is a functionally important distinction: most IRF5 variants are identified through disease association or LD tagging; rs11269962 was identified through its direct impact on transcript levels.

The broader protective haplotype block that rs11269962 tags was established in the 14-cohort European SLE study by Ferreiro-Neira et al.44 14-cohort European SLE study by Ferreiro-Neira et al.
1,383 SLE cases, 1,614 controls; independent protective signal from the 5' IRF5 region, P<10⁻⁶, distinct from the 3' susceptibility signal at rs10488631 (P<10⁻¹⁷). The comprehensive haplotype study by Graham et al. further refined this picture, showing that haplotypes H2 and H3 — both carrying the deletion allele at the rs11269962 position — showed odds ratios of approximately 0.79 and 0.89 for SLE55 odds ratios of approximately 0.79 and 0.89 for SLE
Relative to the population average haplotype frequency, indicating meaningful disease protection.

A notable population stratification exists: the r² between rs11269962 and rs729302 is 0.36 in European samples but below 0.05 in Asian and African populations, meaning the haplotype block architecture differs substantially across ancestries. This weak inter-population LD indicates that rs11269962 captures regulatory variation that is partially independent of rs729302's protective signal — it is not simply a redundant tag but an additional regulatory dimension of the protective haplotype system.

Practical Implications

Because rs11269962 is a 14-bp indel, it is not covered by standard consumer genotyping chips (23andMe v3/v4/v5). Accurate genotyping requires whole-genome sequencing (WGS) with structural variant calling. Individuals with WGS data can use this variant for a more complete picture of their IRF5 regulatory haplotype, particularly when combined with rs729302 and rs13245639 genotypes.

The deletion (D) allele is the protective allele: it tags the low-expression IRF5 haplotypes associated with reduced autoimmune susceptibility. Homozygous DD individuals have both gene copies running on a protective haplotype background; ID heterozygotes carry one protective and one neutral-to-risk copy; II homozygotes carry no deletion-tagged protective haplotype at this specific regulatory locus.

This variant's value is primarily as a functional anchor within the IRF5 protective haplotype architecture. It does not standalone as a clinical diagnostic variant but provides mechanistic context for why the rs729302 protective haplotype works: the upstream regulatory region carries multiple coordinated functional changes, of which rs11269962 represents the single strongest mRNA-expression signal.

Interactions

rs11269962 belongs to the same 5' IRF5 regulatory haplotype block as rs729302 and rs13245639, though with only moderate LD with rs729302 (r²=0.36 in Europeans) and effectively independent in Asian and African populations. The IRF5 locus has a three-block regulatory architecture: the 5' protective block (rs729302, rs13245639, rs11269962, CGGGG indel), the exon 1 splicing block (rs2004640), and the 3' risk block (rs10488631). rs11269962 operates within the 5' protective block but captures independent regulatory variation that rs729302 alone does not fully explain.

The IRF5 expression it influences feeds downstream into the STAT4 signalling pathway (rs7574865), which amplifies cellular responsiveness to type I interferons. Lower IRF5 expression from deletion-allele haplotypes reduces the initial interferon production signal; low-risk STAT4 genotypes then further reduce the amplification of that signal — creating a cumulative dampening of the interferon axis.

Genotype Interpretations

What each possible genotype means for this variant.

II Standard IRF5 Tone Normal

No deletion-allele protective tag; standard IRF5 expression at this upstream locus

You carry two copies of the insertion (I) allele at rs11269962, meaning neither of your IRF5 gene copies runs on the deletion-tagged protective haplotype at this 2.2 kb upstream regulatory locus. Your IRF5 expression regulation here reflects the population baseline — no buffering from the protective deletion haplotype. This is the most common genotype globally; approximately 36% of people worldwide carry this genotype. Your autoimmune disease susceptibility at this specific IRF5 locus is not reduced by this variant, though your overall IRF5 risk profile is shaped by your genotypes at the complementary sites rs729302, rs13245639, and rs10488631.

DI Partial IRF5 Protection Beneficial

One deletion-allele protective tag; one of two IRF5 gene copies runs on a protective haplotype at this upstream locus

The deletion allele at rs11269962 removes a 14-bp sequence that, in the insertion configuration, recruits a repressive nuclear factor detected in EMSA. Paradoxically, the deletion-allele luciferase construct shows higher isolated reporter expression, but at the haplotype level the deletion allele is consistently enriched on low-expression IRF5 haplotypes — meaning the coordinated regulatory architecture of the full protective block overrides the isolated deletion effect. As a heterozygote, you carry one protective block alongside one insertion-allele background whose net autoimmune risk depends substantially on your genotypes at the other IRF5 loci, particularly rs10488631.

Importantly, rs11269962 is approximately 0.36 in r² with rs729302-C in Europeans but essentially independent in East Asian and African populations — meaning this variant captures IRF5 regulatory biology that rs729302 alone does not fully account for, particularly in non-European ancestry individuals.

DD Full IRF5 Protection Beneficial

Two deletion-allele protective tags; both IRF5 gene copies run on a protective haplotype at this upstream regulatory locus

Homozygous DD individuals carry the protective deletion haplotype on both chromosomes at this upstream IRF5 locus. The deletion allele is the most strongly expression-associated polymorphism at the IRF5 5' region by RNA-seq analysis (P=0.002 in Fernández-Hernández et al. 2013), underscoring that this site sits at a key regulatory node for IRF5 transcriptional control.

Because rs11269962 and rs729302 have only moderate LD in Europeans (r²=0.36) and are essentially independent in other populations, DD individuals at rs11269962 do not automatically carry the rs729302-C protective allele — the protective signals are partially complementary. Individuals homozygous for protective alleles at both rs11269962 (DD) and rs729302 (CC) carry the most comprehensively buffered 5' IRF5 regulatory architecture, while those who are rs11269962-DD but rs729302-AA carry protection at this specific upstream locus only.

Note that this variant does not cover autoimmune risk pathways outside the IRF5 interferon-production axis — HLA, PTPN22, STAT4, and other immune-genetic contributors operate independently of this locus.